Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) announced that its executive management team will participate in a fireside chat at the Virtual BTIG Annual Biotech Conference on August 10, 2021, at 2:50 p.m. ET. Interested parties can access the live webcast via the 'Investors' section on Aurinia's corporate website. Additionally, a replay will be provided. Aurinia is a biopharmaceutical company focused on therapies for serious diseases with high unmet medical needs, including its FDA-approved treatment, LUPKYNIS™ (voclosporin), for adult patients with active lupus nephritis.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the executive management team will participate in a fireside chat during the Virtual BTIG Annual Biotech Conference on Tuesday, August 10, 2021 at 2:50 p.m. ET.

In order to participate in the audio webcast, interested parties can access the live webcast under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.

ABOUT AURINIA

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company has introduced LUPKYNIS™ (voclosporin), the first FDA-approved oral therapy dedicated for the treatment of adult patients with active lupus nephritis (LN). The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210809005377/en/

FAQ

When will Aurinia Pharmaceuticals participate in the BTIG Annual Biotech Conference?

Aurinia Pharmaceuticals will participate in the BTIG Annual Biotech Conference on August 10, 2021, at 2:50 p.m. ET.

How can I access the Aurinia Pharmaceuticals fireside chat webcast?

You can access the live webcast of the Aurinia Pharmaceuticals fireside chat through the 'Investors' section of their corporate website.

What is LUPKYNIS™ and its significance for Aurinia Pharmaceuticals?

LUPKYNIS™ (voclosporin) is the first FDA-approved oral therapy for treating active lupus nephritis in adult patients, marking a significant advancement for Aurinia Pharmaceuticals.

Where is Aurinia Pharmaceuticals headquartered?

Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia.

Will there be a replay of the Aurinia Pharmaceuticals webcast?

Yes, a replay of the Aurinia Pharmaceuticals webcast will be available on their corporate website.